HZX-02-059, CAS [[2240205-30-3]]

Produktübersicht

• Artikelname: HZX-02-059, CAS [[2240205-30-3]]
• Artikelnummer: MCE-HY-112440
• Hersteller Artikelnummer: HY-112440
• Alternativnummer: MCE-HY-112440-50MG,MCE-HY-112440-10MG,MCE-HY-112440-5MG,MCE-HY-112440-25MG,MCE-HY-112440-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Methuosis inducer 1

Produktbeschreibung

HZX-02-059 is a potent methuosis inducer and dual-target PIKfyve/tubulin inhibitor with anticancer activity. Methuosis mainly disrupts the balance of endocytosis and exocytosis, forming a large number of vesicles and inducing cell death. HZX-02-059 also induces cell vacuolization, promotes apoptosis, downregulates the p53 pathway, inhibits PI3K/AKT phosphorylation, and inhibits c-Myc and NF-kappaB transcription[1][2].

Produkteigenschaften

• Molekulargewicht: 487.48
• Reinheit: 99.40
• CAS Nummer: [2240205-30-3]
• Formel: C27H20F3N5O
• Target-Kategorie: Others

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound